Table 2.
Operative and postoperative outcomes
| Variables | Values n = 75 |
|---|---|
| Operative procedure, n (%) | |
| High anterior resection | 13 (17.3) |
| Low anterior resection | 59 (78.7) |
| Hartmann | 3 (4.0) |
| Lymph node dissection*, n (%) | |
| prxD2 | 4 (5.3) |
| prxD3 | 71 (94.7) |
| LLND, n (%) | |
| Yes | 3 (4.0) |
| No | 72 (96.0) |
| Total operation time**, min (range) | 303 (187–545) |
| Total console time**, min (range) | 178 (60–301) |
| Estimated blood loss**, g (range) | 0 (0–100) |
| Number of harvested lymph nodes** (range) | 17 (3–36) |
| Transfusion, n (%) | |
| Yes | 1 (1.3) |
| No | 74 (98.7) |
| Postoperative complications, n (%) | |
| CD ≥ II | 20 (26.7) |
| CD ≥ III | 5 (6.7) |
| Resection status, n (%) | |
| R0 | 75 (100.0) |
| R1 | 0 (0.0) |
| Postoperative hospital stay**, days (range) | 13 (9–90) |
LLND lateral pelvic lymph node dissection, TME total mesorectal excision, CD Clavien-Dindo classification
*According to the Japanese Classification of Colorectal, Appendiceal, and Anal carcinoma
**The data are expressed as the median (range)